Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.70136DOI Listing

Publication Analysis

Top Keywords

commentary 'safety
4
'safety pharmacokinetics
4
pharmacokinetics antiviral
4
antiviral efficacy
4
efficacy capsid
4
capsid assembly
4
assembly modulator
4
modulator freethiadine
4
freethiadine healthy
4
healthy volunteers
4

Similar Publications

Emerging systemic treatments for asthma and allergic diseases: New tricks, same dog?

J Allergy Clin Immunol Pract

September 2025

Associate Professor of Medicine, Medical Director of Clinical Asthma Research, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center. Electronic address:

Asthma and allergic diseases are heterogeneous conditions driven by complex immunological pathways, with type 2 (T2) inflammation being a key but not exclusive component. Advances in immunology have spurred interest in a breadth of mechanisms and innovative therapeutic strategies, including novel targets, extended dosing intervals, and combined-target therapies. This clinical commentary provides a critical overview of ongoing clinical trials and emerging evidence supporting the use of these therapies in asthma and other allergic conditions.

View Article and Find Full Text PDF

Background: Chatbots are increasingly utilized in the healthcare landscape, including in sexual and reproductive health (SRH). These tools have shown significant potential in enhancing accessibility to health education and services, particularly with the addition of artificial intelligence. This commentary explores the utilization of chatbots for delivering SRH care, assessing their potential to impact health equity and access within rural and underserved settings and evaluating their effectiveness and safety.

View Article and Find Full Text PDF